Evidence map›Paper›PMID 40539512›Full record

ArticleNucleic acids research2025

A rational engineering strategy for structural dynamics modulation enables target specificity enhancement of the Cas9 nuclease.

Keewon Sung, Youngri Jung, Nahye Kim, Yong-Woo Kim, Hyongbum Henry Kim, Seong Keun Kim, Sangsu Bae

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Keewon SungDepartment of Chemistry, Seoul National University, Seoul 08826, South Korea.ORCID 0000-0002-2733-556X
Youngri JungDepartment of Chemistry, Hanyang University, Seoul 04763, South Korea.ORCID 0000-0003-0952-3361
Nahye KimDepartment of Pharmacology, Yonsei University College of Medicine, Seoul 03722, South Korea.
Yong-Woo KimDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, South Korea.
Hyongbum Henry KimDepartment of Pharmacology, Yonsei University College of Medicine, Seoul 03722, South Korea.ORCID 0000-0002-4693-738X
Seong Keun KimDepartment of Chemistry, Seoul National University, Seoul 08826, South Korea.ORCID 0000-0001-9891-0931
Sangsu BaeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, South Korea.ORCID 0000-0003-3615-8566

Funding

Korean Fund for Regenerative Medicine (KFRM) RS-2024-00332601MSIT RS-2022-NR070713MSIT RS-2023-00260968MSIT RS-2024-00338871MSIT RS-2024-00357556National Research Foundation of Korea 2018R1A2B2001422National Research Foundation of Korea 2021M3A9H3015389National Research Foundation of Korea RS-2024-00451880National Research Foundation of Korea RS-2024-00455559National Research Foundation of Korea SRC-NRF2022R1A5A102641311
6 · The paper itself

Abstract

Structural dynamics of an enzyme plays a crucial role in enzymatic activity and substrate specificity, yet rational engineering of the dynamics for improved enzymatic properties remains a challenge. Here, we present a new biochemical strategy of intermediate state stabilization that modulates the multistep dynamic mechanisms of enzyme reactions to improve substrate specificity. We employ this strategy to enhance CRISPR-Cas9 nuclease specificity. By incorporating positively charged residues into the noncatalytic REC2 domain of Cas9, we stabilize the REC2-DNA interaction that forms exclusively in a catalytically inactive intermediate conformation of the Cas9 complex. This enables off-target trapping in the inactive conformation and thus reduces off-target cleavage in human cells. Furthermore, we combine the REC2 modification with mutations in previous rational variants, leading to the development of a combinational variant named Correct-Cas9, which connotes "combined with rationally engineered REC-Two" Cas9. Assessed by high-throughput analysis at thousands of target sequences, Correct-Cas9 exhibits increased target specificity compared to its parental variants, demonstrating a synergy between our strategy and previous rational approaches. Our method of intermediate state stabilization, either alone or combined with conventional approaches, could be applied to various nucleic acid-processing enzymes that undergo conformational changes upon target binding, to enhance their target specificity effectively.

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsEndonucleasesProtein EngineeringDNAGene EditingHumansModels, MolecularMutationSubstrate SpecificityCRISPR-Associated Protein 9DNAEndonucleases

Identifiers

PMID40539512
PMCPMC12204706

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.